DAC
THL Biobank Data Access Committee
| Dac ID | Contact Person | Access Information | |
|---|---|---|---|
| EGAC00001000660 | Kaisa Silander | admin [dot] biobank [at] thl [dot] fi | https://www.thl.fi/en/web/thlfi-en/topics/information-packages/thl-biobank/researchers/sample-and-data-access |
This DAC controls 8 datasets:
| Dataset ID | Description | Technology | Samples |
|---|---|---|---|
| EGAD00000000026 | Randomly-selected, unrelated individuals | Illumina 610-Quad | 518 |
| EGAD00001000055 | Genetic variation in Kuusamo | Illumina HiSeq 2000 | 434 |
| EGAD00001000200 | Dilgom Exome | Illumina HiSeq 2000 | 130 |
| EGAD00001000299 | Whole exome sequencing of samples selected from the Finrisk sample collection. The samples sequenced in this study have all been collected in Kuusamo, Finland. | Illumina HiSeq 2000 | 24 |
| EGAD00001000403 | The ENGAGE project is a FP7 funded EU project aiming to combine genetic and phenotype information from European population based cohorts. In this sub-project we aim to do whole exome sequencing of individuals selected from Health 2000 and FINRISK cohorts. Individuals have been selected based on their metabolic trait phenotypes | Illumina HiSeq 2000 | 394 |
| EGAD00001001250 | Low coverage (4-6x) sequencing on samples from population cohorts (Finrisk, Health2000) will be done at Wellcome Trust Sanger Institute (WTSI) using Illumina HiSeq sequencing technology. We will produce 100bp paired end reads. Variants will be called using the 1000 Genomes Project pipeline. The samples have been selected from a national representative set of 8028 samples from persons of 30 years or older, which were screened for psychotic and bipolar disorders using the Composite International Diagnostic Interview, self-reported diagnoses, medical examination, and national registers. | Illumina HiSeq 2000 | 731 |
| EGAD00001001251 | Low coverage (4-6x) sequencing on samples from population cohorts (Finrisk, Health2000) will be done at Wellcome Trust Sanger Institute (WTSI) using Illumina HiSeq sequencing technology. We will produce 100bp paired end reads. Variants will be called using the 1000 Genomes Project pipeline. The samples have been selected from a national representative set of approximately 30,300 samples and comprises 500 individuals of each gender in the extreme tail of high density lipoprotein (HDL) concentrations. Included individuals were between 25 and 65 years of age. Individuals with a diagnosis of diabetes or BMI>30 were excluded from the study. | Illumina HiSeq 2000 | 966 |
| EGAD00010000662 | Finnish population cohort genotyping | 0 |
